Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

3.420
-0.470-12.08%
Volume:81.45M
Turnover:281.93M
Market Cap:64.19B
PE:16.86
High:3.570
Open:3.400
Low:3.370
Close:3.890
Loading ...

Sino Biopharmaceutical's Anti-Tumor Drug Gets Implied Approval from China

MT Newswires Live
·
04 Apr

BRIEF-Sino Biopharmaceutical Says Positive Results On Phase 3 Study Of Culmerciclib In Combination With Fulvestrant

Reuters
·
24 Mar

Sino Biopharmaceutical - Positive Results on Phase Iii Study of Culmerciclib in Combination With Fulvestrant

THOMSON REUTERS
·
24 Mar

Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$5.52 From HK$6.42, Keeps at Buy

MT Newswires Live
·
21 Mar

Sino Biopharmaceutical's 2024 Attributable Profit Jumps 50%

MT Newswires Live
·
20 Mar

BRIEF-Sino Biopharmaceutical Recommends Payment Of Final Dividend Of HK4 Cents Per Share

Reuters
·
20 Mar

Sino Biopharmaceutical - Recommended Payment of a Final Dividend of HK4 Cents per Share for Year

THOMSON REUTERS
·
20 Mar

Sino Biopharmaceutical - Recommended Payment of a Final Dividend of HK4 Cents per Share

THOMSON REUTERS
·
20 Mar

Sino Biopharmaceutical - FY Revenue RMB28.87 Bln

THOMSON REUTERS
·
20 Mar

Sino Biopharmaceutical's (HKG:1177) earnings have declined over five years, contributing to shareholders 43% loss

Simply Wall St.
·
13 Mar

Sino Biopharmaceutical's Drug Study Shows 85.2% Failure-Free Survival Rate for 12 Months

MT Newswires Live
·
11 Mar

BRIEF-Sino Biopharmaceutical Enters Exclusive Cooperation Agreement With Delova Biotech For QP001

Reuters
·
06 Mar

Sino Biopharmaceutical - Entering Into an Exclusive Cooperation Agreement With Delova Biotech for Qp001

THOMSON REUTERS
·
06 Mar

Sino Biopharmaceutical - Expects That Product Will Be Approved by National Medical Products Administration of China for Marketing in Near Future

THOMSON REUTERS
·
06 Mar

BRIEF-Sino Biopharmaceutical Signs Exclusive Strategic Cooperation Agreement With Sciwind Biosciences

Reuters
·
27 Feb

Sino Biopharmaceutical - Signing of an Exclusive Strategic Cooperation Agreement With Sciwind Biosciences

THOMSON REUTERS
·
27 Feb

Sino Biopharmaceutical - Co, Sciwind Biosciences Established Exclusivity on Licensing and Cooperation in 19 Countries for Human Interleukin-29 Project

THOMSON REUTERS
·
27 Feb

Sino Biopharmaceutical Limited's (HKG:1177) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.
·
11 Feb

Chinese Regulator Approves Sino Biopharmaceul's Tulobuterol Patches for Marketing

MT Newswires Live
·
07 Feb

Sino Biopharmaceutical's Anti-Inflammatory Medication Gets NMPA's Approval for Marketing

MT Newswires Live
·
07 Feb